Industrial biotechnology -- a chance at redemption
Article Abstract:
The Industrial Biotechnology (IB) vision for the future is based on the opinion that everything from medicines and fuels to clothing fibers and assorted other industrial raw, materials can be made from plants and microorganisms. Petroleum based platform, chemicals and other heavy industries have reached a new inflection point that petroleum and chemistry would slowly be supplanted by renewable agricultural crops and biotechnology.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Immunotherapy: Past, present and future
Article Abstract:
The active immunotherapy with vaccines and passive immunotherapy using unmodified and armed monoclonal antibodies are emerging as useful immunotherareutic strategies. The past approaches, recent developments that suggest major strategies for the development of effective immunotherapies for the treatment of established infectious disease and cancer are discussed.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Synthetic biology offers alternative pathways to natural products
Article Abstract:
Several companies that use modest pathway modeling and classic metabolic engineering are capitalizing on media buzz about synthetic biology and a five-year malaria medicine project. This project launched in December 2004 would produce a low-cost synthetic version of artemisinin and financed by the Gates Foundation.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Industry note: the completion of the Internal European Market and strategies of agribusiness firms. Agribusiness firms: location determinants and economic contribution
- Abstracts: Marriott makes the business case for an innovative total rewards strategy. At Raytheon Six Sigma works, too, to improve HR management processes
- Abstracts: In vivo veritas. In vivo cancer targeting and imaging with semiconductor quantum dots. Human antibodies from immunized donors are protective against anthrax toxin in vivo
- Abstracts: Expense, social and moral control. Accounting and the administration of the old poor law in England and Wales
- Abstracts: Expense, social and moral control. Accounting and the administration of the old poor law in England and Wales. part 2